UNSPSC 51373100: Controlled substance analgesic thiophenes

Controlled substance analgesic drugs made from compounds based on thiofuran, or C4H4S.

UNSPSC 51373100 Controlled substance analgesic thiophenes is a Class code that state and local governments use to procure opioid antagonists, prescription medications, and related pharmaceutical products for public health and emergency response programs. Recent solicitations show procurement of naloxone for overdose reversal and generic multi-source pharmaceuticals for state and local health systems, along with exploratory vendor outreach for direct-to-manufacturer pharmacy programs. Issuing bodies include county health agencies, state health and human services departments, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The work centers on sourcing FDA-regulated pharmaceutical products with documented manufacturing compliance, maintaining supply chain security, and ensuring reliable delivery through authorized wholesalers or direct vendor relationships.

Activity appears across Florida, Texas, and Minnesota, with the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administering a multi-state RFP that includes Oregon. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2023—note the date discrepancy in the source suggesting this solicitation may be historical. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program, functioning as preliminary market intelligence before formal competitive solicitation. Minnesota's MMCAP RFP (S1070000015802), posted January 20, 2026 with a March 26, 2026 response deadline, seeks generic pharmaceuticals and OTC products from manufacturers who must work through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson as authorized wholesalers, with evaluation weighted 75 percent on price competitiveness and the remainder on fixed pricing, compliance, EDI capability, and administrative fee acceptance.